Download our S-1 Preparedness Checklist to help you jumpstart your S-1 process. 

As the IPO landscape shows signs of shifting, companies that wish to access capital in this way must start thinking about their pathway to the public markets.  

The initial step is through filing an S-1 with the Securities Exchange Commission (SEC), which represents the first time a biotech company will disclose details about its business.